Clinical Trial

The HOPE Biobank Resource (BMT CTN 2402 HOPE)

Study acronym: HOPE Resource
Recruiting
View on ClinicalTrials.gov →
Summary
A prospective, multicenter study that will establish a repository of biospecimens and clinical data from patients undergoing hematopoietic stem cell transplant (HCT) or gene therapy (GT) for treatment of non-malignant blood diseases.
Protocol Amendment History 2 changes
critical Recruitment opened 2026-06-17
notable Trial sites expanded: 0 -> 6 locations 2026-06-17
Trial Details
NCT Number NCT07227155
Lead Sponsor Medical College of Wisconsin
Collaborators: National Cancer Institute (NCI), National Institutes of Health (NIH), National Heart, Lung, and Blood Institute (NHLBI)
Conditions Aplastic Anemias, Hemoglobinopathies, Bone Marrow Failure
Enrollment 375 participants
Start Date 2026-05-15
Primary Completion 2031-03-30 (estimated)
Study Completion 2031-03-30 (estimated)
Updated on ClinicalTrials.gov 2026-06-16